Taro Pharmaceutical - ADR Financials

$42.97

$0.00 (0.00%)

As on 21-Jun-2024 19:00EDT

Market cap

$1,615 Mln

Revenue (TTM)

$629 Mln

P/E Ratio

30

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Cash From Operating Activities	--	31.75	-158.70	45.77	271.61	323.71
Cash Flow from Investing Activities	--	--	-170.58	67.74	-298.16	257.14
Cash from Financing Activities	--	--	-24.93	-24.20	-26.98	-588.85
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Adjusted EPS ($)	1.43	0.68	1.55	-10.53	6.38	7.31
Cash EPS ($)	1.43	1.53	2.24	-9.91	6.94	7.79
Adjusted Book Value ($)	47.71	46.05	45.54	44.76	54.99	49.43
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	3.52	0.84	-4.22	1.20	7.10	8.40
Free Cash Flow per Share ($)	2.08	0.37	-4.54	0.75	6.36	7.60

Profitability Ratios	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
ROCE (%)	3.06	1.48	3.41	-21.03	12.18	13.71
ROE (%)	3.06	1.48	3.41	-21.05	12.18	13.71
ROA (%)	2.51	1.18	2.54	-16.88	10.91	12.34
EBIT Margin (%)	--	3.09	32.84	128.32	38.24	39.34
Net Margin (%)	--	4.44	10.38	-73.00	37.88	42.06
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Revenue Growth (%)	0.10	0.02	0.02	-0.15	-0.04	0.01
EBIT Growth (%)	--	-90.39	-73.83	185.74	-6.45	-22.32
Net Profit Growth (%)	111.70	-56.33	114.54	-264.08	-13.32	33.45
EPS Growth (%)	1.12	-0.56	1.15	-2.65	-0.13	0.38
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Price / Earnings	29.54	35.92	27.91	-7.01	9.59	14.79
Price / Book Value	0.89	0.53	0.95	1.65	1.11	2.19
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	13.54	1.25	3.84	2.45	4.88	11.05
Close Price ($)	42.34	24.32	43.26	73.75	61.20	108.09
High Price ($)	45.76	44.49	77.22	80.00	109.42	121.23
Low Price ($)	22.89	22.89	42.68	53.95	56.07	76.93
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Debt to Equity	--	0.00	0.00	0.00	0.00	--
Short term debt to equity ratio	--	0.00	0.00	0.00	0.00	0.01
Current Ratio	3.61	3.47	3.10	2.17	6.88	6.84
Quick Ratio	3.04	2.88	2.61	1.91	6.19	6.16
Interest Coverage	--	1.00	111.53	516.83	340.05	1,029.41

Operating Efficiency Ratios	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Debtors to sales (%)	--	45.29	54.64	48.62	42.00	42.59
Asset Turnover	0.29	0.27	0.24	0.23	0.29	0.29
Receivable days	126.82	180.46	186.61	178.87	157.51	167.59
Inventory Days	243.06	262.05	266.04	241.29	224.44	238.43
Payable days	63.74	81.96	88.10	65.16	47.64	49.50
Cash Conversion Cycle	306.14	360.55	364.54	355.00	334.31	356.52